Veeva Systems Inc

Veeva Systems Inc(VEEV)股票分析

$276.690

-5.340 (-1.93%)收盘时

Loading chart…
High
284.680
Open
280.000
VWAP
279.27
Vol
3.64M
Mkt Cap
29.93B
Low
276.450
Amount
1.02B
EV/EBITDA, TTM
33.66

Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution.

AI analysis of Veeva Systems Inc (VEEV)

buy

Veeva Systems is a good buy right now due to its strong recent performance and positive outlook. The current price is $276.69, with an RSI of 76.97 indicating strong momentum. The company reported Q2 earnings with an EPS of $2.35, exceeding expectations, and has raised its fiscal 2027 sales guidance to between $3.682 billion and $3.687 billion, above analyst estimates. The main risk is the high forward P/E ratio of 27.03, suggesting that the stock may be overvalued if growth slows.

Analyst Ratings (14)

+14.60% upside
Buy
8 Buy
6 Hold
0 Sell
Current: 276.69
最低
222.00
平均
317.10
最高
380.00

Citi

2026-08-28

目标价

$273

Neutral

Truist

2026-08-27

目标价

$305

Buy

Stifel

2026-08-27

目标价

$300

Buy

RBC Capital

2026-08-27

目标价

$325

Outperform

Raymond James

2026-08-27

目标价

$330

Outperform

估值指标

The current forward P/E ratio for Veeva Systems Inc (VEEV) is 27.03, compared to its 5-year average forward P/E of 38.84.

Forward P/E

Fair
5Y Average P/E
38.84
Current P/E
27.03
高估
52.01
低估
25.67

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
29.23
Current EV/EBITDA
33.66
高估
37.25
低估
21.20

Forward P/S

Fair
5Y Average P/S
12.55
Current P/S
11.20
高估
16.00
低估
9.09

Alphio AI Price Scenarios for VEEV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%VEEV

$310.11

情景价格

B

Base

Base · 50%VEEV

$275.56

情景价格

B

Bear

Bear · 25%VEEV

$250.84

情景价格

Whales holding VEEV

T

The Linonia Partnership LP

+ HoldingVEEVTDG

+13.25%

3M Return

P

Peregrine Capital Management, LLC

+ HoldingVEEV

+6.74%

3M Return

D

D.F. Dent and Company, Inc.

+ HoldingVEEV

+5.94%

3M Return

F

Fundsmith, LLP

+ HoldingVEEV

+4.22%

3M Return

N

North Star Asset Management, Inc

+ HoldingVEEV

+4.14%

3M Return

H

Hikari Power Ltd.

+ HoldingVEEV

+3.84%

3M Return

VEEV FAQ — answered by Alphio AI

Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution. It operates in the Healthcare sector (SERVICES-PREPACKAGED SOFTWARE industry).

Veeva Systems is a good buy right now due to its strong recent performance and positive outlook. The current price is $276.69, with an RSI of 76.97 indicating strong momentum. The company reported Q2 earnings with an EPS of $2.35, exceeding expectations, and has raised its fiscal 2027 sales guidance to between $3.682 billion and $3.687 billion, above analyst estimates. The main risk is the high forward P/E ratio of 27.03, suggesting that the stock may be overvalued if growth slows.

14 analysts cover VEEV: 8 rate it Buy, 6 Hold and 0 Sell. The average price target is 317.10.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始